FDA Approves Evolut TAVR System, Medtronic’s Treatment for Symptomatic Severe Aortic Stenosis

Evolut FX+ transcatheter aortic valve replacement system design includes a larger coronary access window through a modified frame.

Source link
#FDA #Approves #Evolut #TAVR #System #Medtronics #Treatment #Symptomatic #Severe #Aortic #Stenosis